low price DoP asks NPPA to review

low price DoP asks NPPA to review

DoP junks Skymap Pharma review plea against NPPA for

22/6/2020 · New Delhi: In a major setback to Skymap Pharmaceuticals Limited, the Department of Pharmaceuticals (DoP) has rejected the review application filed by the drugmaker against a notification issued by the National Pharmaceutical Pricing Authority (NPPA) for fixing the retail price of Fluconazole Tablets 300mg. DoP asks NPPA to examine review applications filed by 10/5/2016 · DoP asks NPPA to examine review applications filed by various pharma cos against NPPA's price fixation Ramesh Shankar, Mumbai Tuesday, May 10, 2016, 08:00 Hrs [IST] The Department of Pharmaceuticals (DoP) has directed the national drug price regulator

DoP asks NPPA to re-fix ceiling price of 'Clotrimazole

12/7/2016 · DoP asks NPPA to re-fix ceiling price of 'Clotrimazole Cream 1%' on review petition filed by Glenmark Ramesh Shankar, Mumbai Tuesday, July 12, 2016, 08:00 Hrs [IST] The Department of Pharmaceuticals (DoP) has directed the National Pharmaceutical Pricing Sun Pharma gets favourable review on carboxymethylcellulose 27/4/2017 · Sun Pharma gets favourable review on carboxymethylcellulose drops 1% as DoP asks NPPA to re-fix ceiling price Ramesh Shankar, Mumbai Thursday, April 27, 2017, 08:00 Hrs [IST] The Department of Pharmaceuticals (DoP) has directed the National

DoP junks Skymap Pharma review plea against NPPA for

22/6/2020 · New Delhi: In a major setback to Skymap Pharmaceuticals Limited, the Department of Pharmaceuticals (DoP) has rejected the review application filed by the drugmaker against a notification issued by the National Pharmaceutical Pricing Authority (NPPA) for fixing the retail price of Fluconazole Tablets 300mg. Stent price cap: Didn’t consider hospital profits, clarifies 19/2/2017 · Senior officials of NPPA and the Department of Pharmaceuticals (DoP) met stent manufacturers and importers on Saturday to review availability of stents in the market. These officials have been getting reports that some companies are trying to create artificial shortage of stents in market post price cap announcement.

Refix ceiling price of Zydus rosuvastatin 20mg plus

9/6/2018 · Giving the decision, DoP stated, “NPPA is hereby directed to refix the retail price of new drug Rosuvastatin 20 mg + Clopidogrel 75 mg as per provision of para 5 (1) read with para 9 (4) of DPCO, 2013, within a period of one month from the date of issue of the order.”. Below is the attached judgment for the same. Post GST, drug firms must cut prices: NPPA16/6/2021 · Post GST, drug firms must cut prices: NPPA. By PTI. Published: 16th Jun 2021 11:41 pm. New Delhi: Drug pricing regulator NPPA has asked pharmaceutical companies and medical device makers to reduce prices on products on which the GST has been lowered in order to pass on the benefit to the consumers. In a notification, the National Pharmaceutical

NPPA fixes prices of 20 drugs, stents made costlier

The NPPA has revised prices of 26 drugs. Some of these are anti-cancer drugs, anti-inflammatory medicines and anaesthetics. Of these 26 drugs, the NPPA has revised the ceiling prices of 10 formulations after the Department of Pharmace-uticals (DoP) issued review orders after the previous NPPA orders were challenged. NPPA allows 50% price hike for ibuprofen, ranitidine, 2/7/2021 · Read more about NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine on Business Standard. These are scheduled drugs (or ones that are under price control) and low priced The product is a monthly auto renewal product. Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal.

DCGI asks NPPA to be vigilant on black-marketing, overpricin

7/7/2020 · New Delhi: Drug Controller General of India V.G. Somani has written to its zonal officers and the National Pharmaceutical Pricing Authority (NPPA) to remain vigilant on sale and black-marketing of No revision in stent prices till February, says National 15/9/2017 · “NPPA will revisit the prices of coronary stents in February 2018 taking into account all the issues," the drug price regulator tweeted, clarifying that there would be no “mid-term" revision

NPPA fixes prices of 20 drugs, stents made costlier

The NPPA has revised prices of 26 drugs. Some of these are anti-cancer drugs, anti-inflammatory medicines and anaesthetics. Of these 26 drugs, the NPPA has revised the ceiling prices of 10 formulations after the Department of Pharmace-uticals (DoP) issued review orders after the previous NPPA orders were challenged. NPPA allows 50% price hike for ibuprofen, ranitidine, 2/7/2021 · Read more about NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine on Business Standard. These are scheduled drugs (or ones that are under price control) and low priced The product is a monthly auto renewal product. Cancellation Policy: You can cancel any time in the future without assigning any reasons, but 48 hours prior to your card being charged for renewal.

to bring more medical devices under price control | Ind

11/5/2017 · However, NITI Aayog, in October 2016, decided to delink the DPCO from the NLEM, and wrest the price control function from the NPPA and vest it with the Department of Pharmaceuticals (DoP). DoP Rejects Cipla’s Review Petition Against Fixing Ceiling P The Department of Pharmaceuticals (DoP) has rejected Indian pharma major Cipla’s review application against fixing the retail prices of emtricitabine+ tenofovir alafenamide tablet (brand Tafmune – EM) containing emtricitabine IP 200mg, tenofovir alafenamide hemifumarate eq. to tenofovir alafenamide 25mg; tenofovir alafenamide tablet containing tenofovir alafenamide hemifumarate eq. to

Department of Pharmaceutical asks industry to regulate promotional practices

25/12/2019 · With concerns over the influence of offering gifts to medical professionals by pharmaceutical companies surging, the Department of Pharmaceutical (DoP) has asked the pharmaceutical industry to step up efforts at self-regulation or it will be compelled to bring in a law to regulate promotional practices in the pharmaceuticals industry. ORS major flouts price cap, calls life-saver ‘energy drink’ 6/8/2017 · ORS major flouts price cap, calls life-saver ‘energy drink’. NEW DELHI: Price control of Oral Rehydration Salt (ORS), a life-saving intervention for diarrhoea, is mired in controversy as the

Exclusive | Prices of medicines used to treat common

3/3/2022 · For the first time in many years, prices of nearly 800 drugs and medical devices under the National List of Essential Medicines (NLEM) are set to increase by over 10 percent, owing to a sharp rise NPPA registration, 2022 nppa conferenceNPPA has fixed retail prices of 14 formulations under Drugs (Prices Control) Order, 2013 based on the decision of 89th Authority meeting dated 28.06.2021: 15/07/2021: O.M Submission of price related information in pursuance to the Trade Margin Rationalization